CollPlant Biotechnologies (CLGN) Net Income (QoQ) (2018 - 2026)
CollPlant Biotechnologies (CLGN) Net Income (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2026 | -115.76% |
| Dec 31, 2025 | 667.64% |
| Sep 30, 2025 | -4.06% |
| Jun 30, 2025 | -103.09% |
| Mar 30, 2025 | 57.50% |
| Dec 31, 2024 | 10.36% |
| Sep 30, 2024 | -2.76% |
| Jun 30, 2024 | -0.36% |
| Mar 31, 2024 | 10.54% |
| Dec 31, 2023 | -7.13% |
| Sep 30, 2023 | -162.41% |
| Jun 30, 2023 | -144.90% |
| Mar 31, 2023 | -15.59% |
| Dec 31, 2022 | 1,100,250,100.00% |
| Sep 30, 2022 | -100.00% |
| Jun 30, 2022 | 311.01% |
| Mar 31, 2022 | -1,728.69% |
| Dec 31, 2021 | 81,724,093.10% |
| Sep 30, 2021 | -100.00% |
| Jun 30, 2021 | -30.01% |